NovaPlex HPV28 2026-95234
Summary
AI-generated · Mar 09, 2026CDC intends to award a sole-source purchase/delivery order to Seegene USA, Inc. for the Novaplex HPV28 Detection Laboratory Tests, under FAR part 13.103-1 (SAP). The contractor shall provide the HPV28 laboratory test.
This is not a competitive procurement and no solicitation is available. Firms that believe they can provide the required services should identify themselves and submit written notification to the Contracting Officer within 10 days from publication. Any determination to pursue competition will be at the Government’s discretion, and information received will be used only to decide whether to conduct a competitive procurement.
The Centers for Disease Control and Prevention (CDC) intends to award, on a sole source basis, a purchase/delivery order to: Seegene USA, Inc, 141 Innovation Drive Ste 200, Irvine, CA 92617. The order is for the Novaplex HPV28 Detetion Laboratory Tests. The authority for this sole source procurement is FAR part 13.103-1 (SAP). The contractor shall, provide HPV28 laboratory test. This is not a request for competitive proposals and no solicitation is available. Firms that believe they can provide the required services are encouraged to identify themselves and give written notification to the Contracting Officer within 10 days from the publication date of this synopsis. A determination by the Government not to compete this proposed action based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Inquiries may be sent to Phil Alexander by facsimile at 770-488-2067, or by email to PALEXANDER@CDC.GOV.
From Combined Synopsis/Solicitation posted on Mar 05, 2026Notice history
1-
Combined Synopsis/Solicitation LATEST Posted Mar 05, 2026
Details
Award Information
Not yet awarded
Contacts
Phone
Phone
Agency
Place of Performance
USA